| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |